Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

ClinicalTrials.gov ID: NCT06024746

Public ClinicalTrials.gov record NCT06024746. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 26, 2026, 6:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Combined Efficacy and Safety of an Early, Intensive, Management Strategy With Finerenone and SGLT2 Inhibitor in Patients Hospitalized With Heart Failure (CONFIRMATION-HF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety of treatment in patients hospitalized with heart failure.

Study identification

NCT ID
NCT06024746
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Colorado Prevention Center
Other
Enrollment
1,500 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 8, 2024
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027
Last update posted
Jul 22, 2026

2024 – 2027

United States locations

U.S. sites
33
U.S. states
17
U.S. cities
33
Facility City State ZIP Site status
CON-10004 Fairhope, AL Investigational Site Fairhope Alabama 36532 Recruiting
CON-10075 El Centro, CA Investigational Site El Centro California 92243 Recruiting
CON-10024 Sacramento, CA Investigational Site Sacramento California 95816 Recruiting
CON-10023, San Francisco, CA San Francisco California 94118 Recruiting
CON-10109, Van Nuys, CA Van Nuys California 91405 Recruiting
CON-10001, Aurora, CO Aurora Colorado 80045 Recruiting
CON-10005, Denver, CO Denver Colorado 80204 Recruiting
CON-10078, Hialeah, FL Hialeah Florida 33012 Recruiting
CON-10105, Miami, FL Miami Florida 33135 Recruiting
CON-10113, Miramar, FL Miramar Florida 33027 Recruiting
CON-10022 Atlanta, GA Investigational Site Atlanta Georgia 30303 Recruiting
CON-10021, Glenview, IL Glenview Illinois 60026 Recruiting
CON-10041, Island Lake, IL Island Lake Illinois 60042 Recruiting
CON-10025, Naperville, IL Naperville Illinois 60540 Recruiting
CON-10019, Peoria, IL Peoria Illinois 61603 Recruiting
CON-10064, Merrillville, IN Merrillville Indiana 46410 Recruiting
CON-10080, Lexington, KY Lexington Kentucky 40503 Recruiting
CON-10086, Louisville, Kentucky Louisville Kentucky 40205 Recruiting
CON-10079, Paducah, KY Paducah Kentucky 42003 Recruiting
CON-10030 Baton Rouge, LA Investigational Site Baton Rouge Louisiana 70808 Recruiting
CON-10090, West Monroe, LA West Monroe Louisiana 71291 Recruiting
CON-10002 Kansas City, MO Investigative Site Kansas City Missouri 64111 Recruiting
CON-10018, Omaha, NE Omaha Nebraska 68105 Recruiting
CON-10318, Charlotte, NC Charlotte North Carolina 28207 Recruiting
CON-10119, Centerville, OH Centerville Ohio 45459 Recruiting
CON-10051, Chattanooga, TN Chattanooga Tennessee 37403 Recruiting
CON-10045 Amarillo, TX Investigational Site Amarillo Texas 79106 Recruiting
CON-10015 Austin, TX Investigational Site Austin Texas 78705 Recruiting
CON-10304, Denison, TX Denison Texas 75020 Recruiting
CON-10301, Fort Worth, TX Fort Worth Texas 76104 Recruiting
CON-10085, Houston, TX Houston Texas 77030 Recruiting
CON-10305, Layton, UT Layton Utah 84041 Recruiting
CON-10009, Norfolk, VA Norfolk Virginia 23507 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

Recently updated Heart Failure trials

Other public records listing Heart Failure. Sorted by last update posted; newest first. Not a recommendation.

All Heart Failure trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06024746, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2026 · Synced Jul 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06024746 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →